Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue

Sep 06 2018

• By Eileen Francis

Related Content

Remoxy Review Shows How Opana ER Experience Changed US FDA Thinking On New Opioid Formulations

Jul 02 2018

Opioid Litigation: Drug Mfrs. Lose Bid To Limit Data Disclosure; First Trials Set For March

Jul 04 2018

Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price

Dec 13 2017

Opioid, NME, And Generic Drugs Changes Plotted In US FDA's 2018 Policy Roadmap

Jan 25 2018

Amphastar's Naloxone Nasal Spray Delayed; User Human Factors Study Among FDA Concerns

Feb 22 2017

Related Companies

Purdue Pharma L.P.

Additional Topics

United States FDA Prescription To OTC Switch Drug Approval Standards OTC Drugs Cosmetics Consumer Respiratory Poisoning Cardiovascular

More from Rx-to-OTC Switch

More from Health

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window